Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T03:47:01.195Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical utility of novel cardiac markers: Let the buyer beware

Published online by Cambridge University Press:  21 May 2015

Grant Innes
Grant Innes*
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC; Emergency Medicine, University of British Columbia, Vancouver, BC
*
Department of Emergency Medicine, St. Paul’s Hospital, 1081 Burrard St., Vancouver BC V6Z 1Y6

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary • Commentaire
Information
Canadian Journal of Emergency Medicine , Volume 8 , Issue 1 , January 2006 , pp. 32 - 36
Copyright
Copyright © Canadian Association of Emergency Physicians 2006

References

1.Lippi, G, Montagnana, M, Salvagno, GL, et al. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. Can J Emerg Med 2006;8(1):27––31.Google Scholar
2.Panju, AA, Hemmelgarn, BR, Guyatt, GH, et al. Is this patient having a myocardial infarction? JAMA 1998;280:1256–63.CrossRefGoogle ScholarPubMed
3.Christenson, J, Innes,GD ,GD, Mcknight, D, et al. A clinical prediction rule for early discharge of patients with chest pain. Ann Emerg Med 2005. In press.Google Scholar
4.Antman, EM, Cohen, M, Bernink, PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835–42.Google Scholar
5.Worster, A, Abu-Laban, R, Innes, GD. Diagnostic testing in emergency medicine. Can J Emerg Med 2002;4:348–55.Google Scholar
6.Christenson, J, Innes, G, McKnight, D, et al. Safety and efficiency of emergency department assessment of chest discomfort. CMAJ 2004;170:18037.CrossRefGoogle ScholarPubMed
7.Innes, G, Christenson, J, Weaver, WD, et al. Diagnostic parameters of CK-MB and myoglobin related to chest pain duration. Can J Emerg Med 2002;4(5):322–30.Google Scholar
8.Worster, A, Devereaux, PJ, Heels-Ansdell, D, et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685–90.Google Scholar
9.Roy, D, Quiles, J, Aldama, G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97:297–301.CrossRefGoogle ScholarPubMed
10.Anwaruddin, S, Januzzi, Jr JL, Baggish, AL, et al. Ischemia-modified albumin improves the usefulness of standard cardiac bio-markers for the diagnosis of myocardial ischemia inthe emergency department setting. Am J Clin Pathol 2005;123:140–5.CrossRefGoogle Scholar
11.Sinha, MK, Roy, D, Gaze, DC, et al. Role of ischemia modified albumin, a new biochemical marker ofmyocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29–34.Google Scholar
12.Bassan, R, Potsch, A, Maisel, A, et al. B-type natriuretic peptide: a novel early marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Europ Heart J 2005;26:234–40.Google Scholar
13.Mueller, C, Scholer, A, Laule-Kilian, K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647–54.Google Scholar